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Does Visceral Pleural Invasion Affect Prognosis in
Stage I Non-Small Cell Lung Cancer?
To the Editor:
We read with interest the paper by Huang and colleagues [1]. It is
an interesting metaanalysis investigating the role of visceral
pleural invasion (VPI) as a prognostic factor in resected stage I
non-small cell lung cancer. In particular, the authors focused
their attention on VPI effect in relation to tumor size. In fact,
some studies suggest that VPI is not inﬂuential in tumors smaller
than 3 cm, not supporting the upstage to T2a.
Instead, their results showed that VPI was associated with a
poorer overall survival and with a higher risk of recurrence in
stage I patients. Moreover, VPI was also independent from tumor
size and histology type in affecting overall survival and
recurrence-free survival. Therefore, they support T2 upstaging in
case of VPI independently by tumor size and suggest the use of
adjuvant treatment (e.g., for stage II patients) independently by
histology.
Ourmain concerns are the characteristics of patients conclusion
in the study. The authors declare that confounders such as type of
operation were adjusted, but do not report any data regarding
margins and nodal dissection. However, it is a common opinion
that the kind of resection, the margin extent, and the hilar nodal
dissection are signiﬁcant in determining overall survival and
recurrence-free survival [2, 3]. Furthermore, these data are
essential when comparing tumors smaller than 3 cm, because
currently many different surgical approaches are usually adopted
in theirmanagement (openversusvideo-assisted, anatomicversus
nonanatomic resection, lobar versus sublobar resection).
Our second concern is the heterogeneity of VPI diagnostic
methods adopted by pathologists in the studies included in this
metaanalysis. This is an important bias as conﬁrmed by the
authors themselves.
To conclude, Huang and coworkers’ results are interesting.
However, to obtain conclusive data regarding the prognostic
factor of VPI in small tumor, a multicenter prospective study is
recommended. 2015 by The Society of Thoracic Surgeons
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CORRECTION
Black MC, Trivedi J, Schumer EM, Bousamra M II, van
Berkel V. Double lung transplants have signiﬁcantly improved
survival compared with single lung transplants in high lung
allocation score patients. Ann Thorac Surg 2014;98:
1737–41.
In the above-referenced article, the authors note an
error in the results section that reads “At 1 and 2 years,
respectively, 49% and 27% of patients with a high
LAS who received a unilateral transplant were alive,
whereas 57% and 32% of patients with a high LAS who
received a bilateral transplant were alive.” The text
should read “At 1 and 2 years, respectively, 66% and
53% of patients with a high LAS who received a uni-
lateral transplant were alive, whereas 78% and 72% of
patients with a high LAS who received a bilateral
transplant were alive.” These are the results as depic-
ted in Figure 2 of the manuscript. The authors regret
this error.0003-4975/$36.00
U
S
